314
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Theory of mind, emotion recognition and emotional reactivity factors in early multiple sclerosis: Results from a South American cohort

ORCID Icon, ORCID Icon, , , , , , , , ORCID Icon & show all

References

  • Almeida, M. B., Going, L. C., & Fragoso, Y. D. (2016). Patients with multiple sclerosis present low levels of empathy. Arquivos de Neuro-Psiquiatria, 74(12), 982–985. https://doi.org/10.1590/0004-282x20160154.
  • Amato, M. P., Goretti, B., Brescia Morra, V., Gallo, P., Zaffaroni, M., Onofrj, M., Cocco, E., Borriello, G., Zipoli, V., & Trojano, M. (2020). Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis. Neurological Sciences, 41(11), 3185–3193. https://doi.org/10.1007/s10072-020-04320-w.
  • Banati, M., Sandor, J., Mike, A., Illes, E., Bors, L., Feldmann, A., Herold, R., & Illes, Z. (2010). Social cognition and Theory of Mind in patients with relapsing-remitting multiple sclerosis. European Journal of Neurology, 17(3), 426–433. https://doi.org/10.1111/j.1468-1331.2009.02836.x.
  • Baron-Cohen, S., O’Riordan, M., Stone, V., Jones, R., & Plaisted, K. (1999). Recognition of faux pas by normally developing children and children with Asperger syndrome or high-functioning autism. Journal of Autism and Developmental Disorders, 29(5), 407–418. 10.1023/a:1023035012436.
  • Baron-Cohen, S., & Wheelwright, S. (2004). The empathy quotient: An investigation of adults with asperger syndrome or high functioning autism, and normal sex differences. Journal of Autism and Developmental Disorders, 34(2), 163–175. https://doi.org/10.1023/B:JADD.0000022607.19833.00.
  • Baron-Cohen, S., Wheelwright, S., Hill, J., Raste, Y., & Plumb, I. (2001). The “Reading the Mind in the Eyes” Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. Journal of Child Psychology and Psychiatry, 42(2), 241–251. https://doi.org/10.1111/1469-7610.00715.
  • Batista, S., d’Almeida, O. C., Afonso, A., Freitas, S., Macário, C., Sousa, L., Castelo-Branco, M., Santana, I., & Cunha, L. (2017). Impairment of social cognition in multiple sclerosis: Amygdala atrophy is the main predictor. Multiple Sclerosis, 23(10), 1358–1366. https://doi.org/10.1177/1352458516680750.
  • Berneiser, J., Wendt, J., Grothe, M., Kessler, C., Hamm, A. O., & Dressel, A. (2014). Impaired recognition of emotional facial expressions in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders, 3(4), 482–488. https://doi.org/10.1016/j.msard.2014.02.001.
  • Bradley, M. M., & Lang, P. J. (1994). Measuring emotion: The self-assessment manikin and the semantic differential. Journal of Behavior Therapy and Experimental Psychiatry, 25(1), 49–59. https://doi.org/10.1016/0005-7916(94)90063-9.
  • Cáceres, F., Vanotti, S., & Rao, S. (2011). RECONEM Workgroup. Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country. Journal of Clinical and Experimental Neuropsychology, 33(10):1094–1098. https://doi.org/10.1080/13803395.2011.603690.
  • Chalah, M. A., & Ayache, S. S. (2017). Deficits in social cognition: An unveiled signature of multiple sclerosis. Journal of the International Neuropsychological Society, 23(3), 266–286. https://doi.org/10.1017/S1355617716001156.
  • Chen, M. H., Goverover, Y., Genova, H. M., & DeLuca, J. (2020). Cognitive efficacy of pharmacologic treatments in multiple sclerosis: A systematic review. CNS Drugs, 34(6), 599–628. https://doi.org/10.1007/s40263-020-00734-4.
  • Ciampi, E., Uribe-San-Martin, R., Vásquez, M., Ruiz-Tagle, A., Labbe, T., Cruz, J. P., Lillo, P., Slachevsky, A., Reyes, D., Reyes, A., & Cárcamo-Rodríguez, C. (2018). Relationship between Social Cognition and traditional cognitive impairment in Progressive Multiple Sclerosis and possible implicated neuroanatomical regions. Multiple Sclerosis and Related Disorders, 20, 122–128. https://doi.org/10.1016/j.msard.2018.01.013.
  • Cotter, J., Firth, J., Enzinger, C., Kontopantelis, E., Yung, A. R., Elliott, R., & Drake, R. J. (2016). Social cognition in multiple sclerosis: A systematic review and meta-analysis. Neurology, 87(16), 1727–1736. https://doi.org/10.1212/WNL.0000000000003236.
  • Davidson, R. J. (1998). Affective style and affective disorders: Perspectives from affective neuroscience. Cognition & Emotion, 12(3), 307–330. https://doi.org/10.1080/13803395.2011.603690.
  • Di Bitonto, L., Longato, N., Jung, B., Fleury, M., Marcel, C., Collongues, N., de Seze, J., & Blanc, F. (2011). Moindre réactivité émotionnelle aux stimuli négatifs dans la sclérose en plaques, résultats préliminaires [Reduced emotional reactivity to negative stimuli in multiple sclerosis, preliminary results]. Revue Neurologique, 167(11), 820–826. https://doi.org/10.1016/j.neurol.2011.01.024.
  • Dulau, C., Deloire, M., Diaz, H., Saubusse, A., Charre-Morin, J., Prouteau, A., & Brochet, B. (2017). Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis. Journal of Neurology, 264(4), 740–748. https://doi.org/10.1007/s00415-017-8417-z.
  • Dziobek, I., Fleck, S., Kalbe, E., Rogers, K., Hassenstab, J., Brand, M., Kessler, J., Woike, J. K., Wolf, O. T., & Convit, A. (2006). Introducing MASC: a movie for the assessment of social cognition. Journal of Autism and Developmental Disorders, 36(5), 623–636.
  • Ekman, P., & Friesen, W. V. (1976). Pictures of Facial Affect, Consulting Psychologists Press.
  • Ferreira, M. L. B. (2010). Cognitive deficits in multiple sclerosis: A systematic review. Arquivos de Neuro-Psiquiatria, 68(4), 632–641. https://doi.org/10.1590/S0004-282X2010000400029.
  • Fuso Simone, F., Callegaro, D., Pompéia, S., & Bueno, O. F. A. (2010). Working memory impairment in multiple sclerosis relapsing-remitting patients with episodic memory deficits. Arquivos de Neuro-Psiquiatria, 68(2), 205–211. https://doi.org/10.1590/S0004-282X2010000200010.
  • Genova, H. M., Lancaster, K., Lengenfelder, J., Bober, C. P., DeLuca, J., & Chiaravalloti, N. D. (2020). Relationship between social cognition and fatigue, depressive symptoms, and anxiety in multiple sclerosis. Journal of Neuropsychology, 14(2), 213–225. https://doi.org/10.1111/jnp.12185.
  • Gonzalez-Gadea, M. L., Baez, S., Torralva, T., Castellanos, F. X., Rattazzi, A., Bein, V., Rogg, K., Manes, F., & Ibanez, A. (2013). Cognitive variability in adults with ADHD and AS: Disentangling the roles of executive functions and social cognition. Research in Developmental Disabilities, 34(2), 817–883.
  • Grzegorski, T., & Losy, J. (2017). Cognitive impairment in multiple sclerosis – A review of current knowledge and recent research. Reviews in the Neurosciences, 28(8), 11. https://doi.org/10.1515/revneuro-2017-0011.
  • Harkness, K., Sabbagh, M., Jacobson, J., Chowdrey, N., & Chen, T. (2005). Enhanced accuracy of mental state decoding in dysphoric college students. Cognition & Emotion, 19(7), 999–1025. https://doi.org/10.1080/02699930541000110.
  • Hayes, C. J., Stevenson, R. J., & Coltheart, M. (2009). The processing of emotion in patients with Huntington’s disease: variability and differential deficits in disgust. Cognitive and Behavioral Neurology, 22(4), 249–257. https://doi.org/10.1097/WNN.0b013e3181c124af.
  • Henry, J. D., Phillips, L. H., Beatty, W. W., McDonald, S., Longley, W. A., Joscelyne, A., & Rendell, P. G. (2009). Evidence for deficits in facial affect recognition and theory of mind in multiple sclerosis. Journal of the International Neuropsychological Society, 15(2), 277–285. https://doi.org/10.1017/S1355617709090195.
  • Henry, A., Tourbah, A., Chaunu, M. P., Rumbach, L., Montreuil, M., & Bakchine, S. (2011). Social cognition impairments in relapsing-remitting multiple sclerosis. Journal of the International Neuropsychological Society, 17(6), 1122–1131. https://doi.org/10.1017/S1355617711001147.
  • Keightley, M. L., Winocur, G., Burianova, H., Hongwanishkul, D., & Grady, C. L. (2006). Age effects on social cognition: Faces tell a different story. Psychology and Aging, 21(3), 558–572. https://doi.org/10.1037/0882-7974.21.3.558.
  • Kordsachia, C. C., Labuschagne, I., Andrews, S. C., & Stout, J. C. (2018). Diminished facial EMG responses to disgusting scenes and happy and fearful faces in Huntington’s disease. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior, 106, 185–199. https://doi.org/10.1016/j.cortex.2018.05.019.
  • Kraemer, M., Herold, M., Uekermann, J., Kis, B., Wiltfang, J., Daum, I., Dziobek, I., Berlit, P., Diehl, R. R., & Abdel-Hamid, M. (2013). Theory of mind and empathy in patients at an early stage of relapsing remitting multiple sclerosis. Clinical Neurology and Neurosurgery, 115(7), 1016–1022. https://doi.org/10.1016/j.clineuro.2012.10.027.
  • Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology, 46(10), 1121–1123. Oct
  • Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 33(11), 1444–1452.
  • Lang, P. J., Bradley, M. M., & Cuthbert, B. N. (1997). International affective picture system (IAPS): Affective ratings of pictures and instruction manual. Technical Report A-8. University of Florida.
  • Li, S., Zhang, Y. J., & Tan, H. C. (2010). International Conference on Image Processing (ICIP)., Discovering Latent Semantic Factors for Emotional Picture Categorization. IEEE1065–1068. https://doi.org/10.1109/ICIP.2010.5652558.
  • Louwerse, A., Tulen, J. H., van der Geest, J. N., van der Ende, J., Verhulst, F. C., & Greaves-Lord, K. (2014). Autonomic responses to social and nonsocial pictures in adolescents with autism spectrum disorder. Autism Research, 7(1), 17–27. https://doi.org/10.1002/aur.1327.
  • Lugnegård, T., Unenge Hallerbäck, M., Hjärthag, F., & Gillberg, C. (2013). Social cognition impairments in Asperger syndrome and schizophrenia. Schizophrenia Research, 143(2–3), 277–284. https://doi.org/10.1016/j.schres.2012.12.001.
  • Mattioli, F., Stampatori, C., Bellomi, F., Scarpazza, C., & Capra, R. (2015). Natalizumab significantly improves cognitive impairment over three years in MS: Pattern of disability progression and preliminary MRI findings. PLoS One, 10(7), e0131803. https://doi.org/10.1371/journal.pone.0131803.
  • Mikels, J. A., Fredrickson, B. L., Larkin, G. R., Lindberg, C. M., Maglio, S. J., & Reuter-Lorenz, P. A. (2005). Emotional category data on images from the International Affective Picture System. Behavior Research Methods, 37(4), 626–630. https://doi.org/10.3758/bf03192732.
  • Neuhaus, M., Bagutti, S., Yaldizli, Ö., Zwahlen, D., Schaub, S., Frey, B., Fischer-Barnicol, B., Burgunder, J.-M., Martory, M.-D., Pöttgen, J., Annoni, J.-M., & Penner, I.-K. (2018). Characterization of social cognition impairment in multiple sclerosis. European Journal of Neurology, 25(1), 90–96. https://doi.org/10.1111/ene.13457.
  • Ouellet, J., Scherzer, P. B., Rouleau, I., Métras, P., Bertrand-Gauvin, C., Djerroud, N., Boisseau, E., & Duquette, P. (2010). Assessment of social cognition in patients with multiple sclerosis. Journal of the International Neuropsychological Society, 16(2), 287–296. https://doi.org/10.1017/S1355617709991329.
  • Pais-Ribeiro, J. L., Martins da Silva, A., Vilhena, E., Moreira, I., Santos, E., & Mendonça, D. (2018). The hospital anxiety and depression scale, in patients with multiple sclerosis. Neuropsychiatric Disease and Treatment, 14, 3193–3197. https://doi.org/10.1037/t03589-000.
  • Penner, I. K., Stemper, B., Calabrese, P., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H. P., Miller, D. H., Montalbán, X., Barkhof, F., Pleimes, D., Lanius, V., Pohl, C., Kappos, L., & Sandbrink, R. (2012). Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis. Multiple Sclerosis, 18(10), 1466–1471. https://doi.org/10.1177/1352458512442438.
  • Pfaff, L., Lamy, J., Noblet, V., Gounot, D., Chanson, J. B., de Seze, J., & Blanc, F. (2019). Emotional disturbances in multiple sclerosis: A neuropsychological and fMRI study. Cortex; A Journal Devoted to the Study of the Nervous System and Behavior, 117, 205–216. https://doi.org/10.1016/j.cortex.2019.02.017.
  • Phillips, L. H., Henry, J. D., Scott, C., Summers, F., Whyte, M., & Cook, M. (2011). Specific impairments of emotion perception in multiple sclerosis. Neuropsychology, 25(1), 131–136. https://doi.org/10.1037/a0020752.
  • Pitteri, M., Genova, H., Lengenfelder, J., DeLuca, J., Ziccardi, S., Rossi, V., & Calabrese, M. (2019). Social cognition deficits and the role of amygdala in relapsing remitting multiple sclerosis patients without cognitive impairment. Multiple Sclerosis and Related Disorders, 29, 118–123. https://doi.org/10.1016/j.msard.2019.01.030.
  • Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., Lublin, F. D., Montalban, X., O’Connor, P., Sandberg-Wollheim, M., Thompson, A. J., Waubant, E., Weinshenker, B., & Wolinsky, J. S. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology, 69(2), 292–302. https://doi.org/10.1002/ana.22366.
  • Pöttgen, J., Dziobek, I., Reh, S., Heesen, C., & Gold, S. M. (2013). Impaired social cognition in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 84(5), 523–528. https://doi.org/10.1136/jnnp-2012-304157.
  • Preziosa, P., Rocca, M. A., Riccitelli, G. C., Moiola, L., Storelli, L., Rodegher, M., Comi, G., Signori, A., Falini, A., & Filippi, M. (2020). Effects of natalizumab and fingolimod on clinical, cognitive, and magnetic resonance imaging measures in multiple sclerosis. Neurotherapeutics, 17(1), 208–217. https://doi.org/10.1007/s13311-019-00781-w.
  • Prochnow, D., Donell, J., Schäfer, R., Jörgens, S., Hartung, H. P., Franz, M., & Seitz, R. J. (2011). Alexithymia and impaired facial affect recognition in multiple sclerosis. Journal of Neurology, 258(9), 1683–1688. https://doi.org/10.1007/s00415-011-6002-4.
  • Raimo, S., Trojano, L., Pappacena, S., Alaia, R., Spitaleri, D., Grossi, D., & Santangelo, G. (2017). Neuropsychological correlates of theory of mind deficits in patients with multiple sclerosis. Neuropsychology, 31(7), 811–821. https://doi.org/10.1037/neu0000372.
  • Roca, M., Manes, F., Gleichgerrcht, E., Ibáñez, A., González de Toledo, M. E., Marenco, V., Bruno, D., Torralva, T., & Sinay, V. (2014). Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis. Cognitive and Behavioral Neurology, 27(1), 25–30. https://doi.org/10.1097/wnn.0000000000000017.
  • Roelofs, R. L., Wingbermühle, E., Egger, J. I. M., & Kessels, R. P. C. (2017). Social cognitive interventions in neuropsychiatric patients: A meta-analysis. Brain Impairment, 18(1), 138–173. https://doi.org/10.1017/BrImp.2016.31.
  • Román, F., Rojas, G., Román, N., Iturry, M., Blanco, R., Leis, A., Bartoloni, L., & Allegri, R. F. (2012). Baremos del Test de la Mirada en español en adultos normales de Buenos Aires. Revista Neuropsicología Latinoamericana, 4(3), 1–5. https://www.redalyc.org/articulo.oa?id=439542499003
  • Schmidt, S. J., Mueller, D. R., & Roder, V. (2011). Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. Schizophrenia Bulletin, 37(suppl 2), S41–S54. https://doi.org/10.1093/schbul/sbr079.
  • Simeoni, M., Auquier, P., Fernandez, O., Flachenecker, P., Stecchi, S., Constantinescu, C., Idiman, E., Boyko, A., Beiske, A., Vollmer, T., Triantafyllou, N., O’Connor, P., Barak, Y., Biermann, L., Cristiano, E., Atweh, S., Patrick, D., Robitail, S., Ammoury, N., … Pelletier, J. (2008). Validation of the Multiple Sclerosis International Quality of Life questionnaire. Multiple Sclerosis, 14(2), 219–230. https://doi.org/10.1177/1352458507080733.
  • Sprenger, T., Lechner-Scott, J., Sormani, M. P., Wolinsky, J. S., Wuerfel, J., Thangavelu, K., Cavalier, S., Mandel, M., & Kappos, L. (2018). Evaluation of the long-term treatment effect of teriflunomide on cognitive outcomes and association with brain volume change: data from temso and its extension study. Journal of Neurology, Neurosurgery & Psychiatry, 89(6), A28.1–A28. https://doi.org/10.1136/jnnp-2018-ANZAN.67.
  • Sumowski, J. F., Benedict, R., Enzinger, C., Filippi, M., Geurts, J. J., Hamalainen, P., Hulst, H., Inglese, M., Leavitt, V. M., Rocca, M. A., Rosti-Otajarvi, E. M., & Rao, S. (2018). Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology, 90(6), 278–288. https://doi.org/10.1212/WNL.0000000000004977.
  • Valle, A., Massaro, D., Castelli, I., & Marchetti, A. (2015). Theory of mind development in adolescence and early adulthood: The growing complexity of recursive thinking ability. Europe’s Journal of Psychology, 11(1), 112–124. https://doi.org/10.5964/ejop.v11i1.829.
  • van der Hiele, K., van Egmond, E., Jongen, P. J., van der Klink, J., Beenakker, E., van Eijk, J., Frequin, S., Hoitsma, E., Mostert, J. P., Verhagen, W., van Gorp, D., Middelkoop, H., & Visser, L. H. (2020). Empathy in multiple sclerosis-correlates with cognitive, psychological and occupational functioning. Multiple Sclerosis and Related Disorders, 41, 102036. https://doi.org/10.1016/j.msard.2020.102036.
  • Vijay Kumar, K. (2012). Content based image retrieval system consume semantic gap. International Journal of Computer Science and Information Technologies, 3(5), 5231–5235.
  • Wasser, C. I., Evans, F., Kempnich, C., Glikmann-Johnston, Y., Andrews, S. C., Thyagarajan, D., & Stout, J. C. (2018). Emotion recognition in Parkinson’s disease: Static and dynamic factors. Neuropsychology, 32(2), 230–234. https://doi.org/10.1037/neu0000400.
  • Weinstein, A., Schwid, S. R., Schiffer, R. B., McDermott, M. P., Giang, D. W., & Goodman, A. D. (1999). Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Archives of Neurology, 56(3), 319–324. https://doi.org/10.1001/archneur.56.3.319.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.